10.01.2018

Dr Bartl Wimmer to retire as SYNLAB Group CEO in April 2018 Deputy CEO Mathieu Floreani to succeed as Group CEO from 2 April 2018

Munich, 10 January 2018 – SYNLAB Group (‘SYNLAB’ or ‘the Group’) the leading European provider of medical diagnostic services, today announces that Dr Bartl Wimmer will retire as Group Chief Executive Officer with effect from 2 … 

Kategorie: Corporation, Corporate News
08.09.2017

SYNLAB ernennt neuen CBO für Entwicklung in der nächsten Wachstumsphase

Neue CBO-Rolle spiegelt das Bestreben der SYNLAB wider die Herausforderungen zu bewältigen, die sich aus unserem anhaltenden Wachstum in den geografischen Regionen und dem zunehmenden Umfang des Geschäfts ergebenDr. Bartl Wimmer, … 

Kategorie: Corporation, Corporate News
10.07.2017

SYNLAB acquires Finnish diagnostic services provider Cityterveys

Acquisition of Cityterveys allows SYNLAB to become one of the largest independent integrated diagnostic services provider in Finland. Munich, 10 July 2017 – SYNLAB Limited ("SYNLAB" and “the Group”), the leading medical … 

Kategorie: Corporate News, Corporation
03.07.2017

SYNLAB completes acquisition of ALcontrol

Munich, 3 July 2017 – SYNLAB Limited (together with its subsidiaries ‘the Group’) announces that following receipt of applicable approvals from the relevant regulatory authorities, the Group has completed today the acquisition of … 

Kategorie: Corporate News, Corporation
19.06.2017

New CFO SYNLAB Group

Munich, 19 June 2017 – Synlab Group (‘Synlab’ or ‘the Group’) today announces the appointment of Sami Badarani as Group CFO with effect from July 1, 2017. 

Kategorie: Corporate News, Corporation
19.05.2017

SYNLAB agrees to acquire ALcontrol

Munich, 19 May 2017 – SYNLAB Limited (also "SYNLAB", and together with its subsidiaries the “Group”), the leading provider of laboratory services in Europe, today announces an agreement to acquire ALcontrol Group Limited … 

Kategorie: Corporate News, Corporation
12.04.2017

Novo increases stake in SYNLAB

Munich / Hellerup, 12 April 2017 – SYNLAB Limited (“SYNLAB” or “the Group”), a European market leader for laboratory diagnostics, and Novo A/S (“Novo”), the holding company for the Novo Group and fully owned subsidiary of the … 

Kategorie: Corporate News, Corporation
15.12.2016

Novo A/S becomes a strategic investor in SYNLAB

Munich / Hellerup, 15 December 2016 – SYNLAB Limited (“SYNLAB” or “the Group”) and Novo A/S (“Novo”), the holding company for the Novo Group, today jointly announce that Novo has exercised its option to acquire a stake in the … 

Kategorie: Corporate News, Corporation
18.11.2016

SYNLAB successfully raised almost EUR 1 billion and will pursue its strategic acquisitions

SYNLAB (also the "Group"), the leading provider of laboratory services in Europe, announced earlier this week the closing of the offering of Senior Secured Floating Rate Notes (the “Notes”). Taking advantage of the favourable … 

Kategorie: Corporate News, Corporation
08.06.2016

Dr Christoph Mahnke appointed new CEO and managing director of SYNLAB Holding Deutschland GmbH

Augsburg, 08.06.2016 – Dr Christoph Mahnke will assume the position of CEO and managing director of SYNLAB Holding Deutschland GmbH effective 1 October 2016. SYNLAB Holding Deutschland is the German subsidiary of Europe’s largest … 

Kategorie: Corporate News, Corporation